Axsome Price To Sales Ratio from 2010 to 2025

AXSM Stock  USD 131.52  6.23  4.52%   
Axsome Therapeutics Price To Sales Ratio yearly trend continues to be very stable with very little volatility. Price To Sales Ratio is likely to drop to 9.99. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Axsome Therapeutics' market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
10.5110151
Current Value
9.99
Quarterly Volatility
20.72338992
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Axsome Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axsome Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.3 M, Interest Expense of 3.3 M or Selling General Administrative of 431.9 M, as well as many indicators such as Price To Sales Ratio of 9.99, Dividend Yield of 0.0 or PTB Ratio of 74.66. Axsome financial statements analysis is a perfect complement when working with Axsome Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Axsome Therapeutics Correlation against competitors.
To learn how to invest in Axsome Stock, please use our How to Invest in Axsome Therapeutics guide.

Latest Axsome Therapeutics' Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Axsome Therapeutics over the last few years. Price to Sales Ratio is figured by comparing Axsome Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Axsome Therapeutics sales, a figure that is much harder to manipulate than other Axsome Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Axsome Therapeutics' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axsome Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 17.42 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
13.3610.519.99100%
       Timeline  

Axsome Price To Sales Ratio Regression Statistics

Arithmetic Mean53.04
Geometric Mean45.37
Coefficient Of Variation39.07
Mean Deviation15.66
Median62.67
Standard Deviation20.72
Sample Variance429.46
Range52.6793
R-Value(0.68)
Mean Square Error247.81
R-Squared0.46
Significance0
Slope(2.96)
Total Sum of Squares6,442

Axsome Price To Sales Ratio History

2025 9.99
2024 10.51
2023 13.36

About Axsome Therapeutics Financial Statements

Axsome Therapeutics investors utilize fundamental indicators, such as Price To Sales Ratio, to predict how Axsome Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Price To Sales Ratio 10.51  9.99 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Axsome Therapeutics is a strong investment it is important to analyze Axsome Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Axsome Therapeutics' future performance. For an informed investment choice regarding Axsome Stock, refer to the following important reports:
Check out the analysis of Axsome Therapeutics Correlation against competitors.
To learn how to invest in Axsome Stock, please use our How to Invest in Axsome Therapeutics guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axsome Therapeutics. If investors know Axsome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axsome Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.99)
Revenue Per Share
8.05
Quarterly Revenue Growth
0.66
Return On Assets
(0.27)
Return On Equity
(2.32)
The market value of Axsome Therapeutics is measured differently than its book value, which is the value of Axsome that is recorded on the company's balance sheet. Investors also form their own opinion of Axsome Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Axsome Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axsome Therapeutics' market value can be influenced by many factors that don't directly affect Axsome Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axsome Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Axsome Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axsome Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
News Freq…Investor S…100%